Impact of immunosuppressive therapy on pulmonary perfusion in kidney transplant recipients after COVID-19 illness
Our findings are consistent with the observation that the use of mTORi could play a potentially beneficial role in improving pulmonary perfusion.
Authors
- Luca Macarini (ORCID: https://orcid.org/0000-0003-0484-9645)
- Silvia Mercuri
- Matteo Gravina (ORCID: https://orcid.org/0000-0001-9601-8253)
- Giuseppe Stefano Netti (ORCID: https://orcid.org/0000-0003-3495-2707)
- Giovanni Stallone (ORCID: https://orcid.org/0000-0002-2862-9017)
- Giuseppe Castellano
- Maddalena Panico
- Carlo Alfieri (ORCID: https://orcid.org/0000-0003-3860-5219)
- Elena Ranieri (ORCID: https://orcid.org/0000-0002-4996-3938)
- Barbara Infante
- Dario Troise (ORCID: https://orcid.org/0000-0003-2648-6021)
- Francesca Fortunato (ORCID: https://orcid.org/0000-0003-0665-5385)
- Bruno Minopoli (ORCID: https://orcid.org/0009-0009-1793-1585)
- Carmen Montanile (ORCID: https://orcid.org/0009-0008-8111-2659)
- Marcella Gambacorta
- Anna Rita Cappiello
Institutions
- University of Foggia (IT)
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT)
- Karolinska Institutet (SE)
- Baxter (Sweden) (SE)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2025-06-11
- DOI
- https://doi.org/10.3389/fmed.2025.1562407
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00